LOGIN
Health-related QoL in osteoporotic women improved with zoledronic acid infusions
March 2014
Health-related QoL in osteoporotic women improved with zoledronic acid infusions
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT
Bone. 2011 Jun 1;48(6):1298-304. doi: 10.1016/j.bone.2011.03.719. Epub 2011 Mar 21Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
This study included a subset of 1434 participants from the Health Outcomes and Reduced Incidence with Zoledronic acid ONce yearly (HORIZON) Pivotal Fracture Trial, examining the effect of zoledronic acid on health-related quality of life in postmenopausal, osteoporotic women. After 3 years of follow-up, participants treated with annual infusions of zoledronic acid displayed a significant improveme...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.